Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01482195 (ClinicalTrials.gov)	August 2011	28/9/2011	Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK)	Phase I Trial ofOcular SubretinalInjection ofa Recombinant Adeno-Associated Virus(rAAV2-VMD2-hMERTK) ...	Retinal Disease;Retinitis Pigmentosa	Biological: Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus	King Khaled Eye Specialist Hospital	King Faisal Specialist Hospital & Research Center	Completed	14 Years	70 Years	All	6	Phase 1	Saudi Arabia

First Previous1Next Last